Platelets play an essential role in the aetiology of cerebral vasospasm after subarachnoid haemorrhage

Medical Hypotheses

Volumn 60, Issue 4, 2003, Pages 525-530

  Pyne, Gail J ^a   Cadoux Hudson, Thomas A D ^b   Clark, Joseph F ^a,c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THROMBOCYTE FUNCTION;

EID: 0037375712     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00452-8     Document Type: Article

References (44)

1. Weir B. et al. Time course of vasospasm in man. J Neurosurg 1978; 48: 173-178.
2. Lindegaard K. F. et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989; 100(1-2): 12-24.
3. MacDonald R. L. Cerebral vasospasm. In: Primer on cerebrovascular diseases. San Diego, CA: Academic Press, 1997: 490-496.
4. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995; 9: 375-390.
5. Cadoux-Hudson T. A. D., Pyne G. J., Clark J. F. Subarachnoid haemorrhage-induced cerebral vasospasm: a subcellular perspective on the control of tension. Emerging Therapeutic Targets 1999; 3(3): 439-452.
6. Cadoux-Hudson T. A. D. et al. The stimulation of vascular smooth muscle oxidative metabolism by CSF from subarachnoid haemorrhage patients. Acta Neurochir 2001; 143(1): 65-72.
7. Pyne G. J., Cadoux-Hudson T. A. D., Clark J. F. The presence of an extractable substance in the CSF of humans with cerebral vasospasm after subarachnoid haemorrhage that correlates with phosphatase inhibition. Biochim Biophys Acta 2000; 1474: 283-290.
8. Pyne G. J., Cadoux-Hudson T. A. D., Clark J. F. Cerebral spinal fluid from sub-arachnoid haemorrhage patients causes excessive oxidative metabolism compared to vascular smooth muscle force generation. Acta Neurochirurgica 2001; 142(12): 59-63.
9. Gailly P. et al. Regions of the 110-kDa regulatory subunit M110 required for regulation of myosin light chain phosphatase activity in smooth muscle. Eur J Biochem 1996; 239: 326-332.
10. MacDonald J. A. et al. Identification of the endogenous smooth muscle myosin phosphatase associated kinase. Proc Natl Acad Sci USA 2001; 98(5): 2419-2424.
11. 2- sensitization of smooth muscle contraction through activation of rho-kinase. Pflugers Arch 2001; 441: 597-603.
12. Muranyi A. et al. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett 2001; 493: 80-84.
13. Butler W. E. et al. Intracellular calcium, myosin light chain phosphorylation and contractile force in experimental cerebral vasospasm. Neurosurgery 1996; 38(4): 781-788.
14. Kim I. et al. Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 2000; 46(2): 440-447.
15. Ohta S. et al. Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage. Acta Neurochir (Wien) 1995; 137: 217-225.
16. Szekeres C. K. et al. Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 2000; 275: 690-695.
17. Tang D. G. et al. Transcriptional activation of endothelial cell integrin alpha-V by protein kinase C activator 12(S)-HETE. J Cell Sci 1995; 108: 2629-2644.
18. Chen W. et al. Lipooxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart. Am J Physiol 1999; 276(Heart Circ. Physiol.): H2094-H2101.
19. Hamberg M., Samulelsson B. Prostaglandin endoperoxides: novel transformations of arachidonic acids in human platelets. Proc Natl Acad Sci USA 1974; 721: 3400-3404.
20. Juvela S., Kaste M., Hillborn M. Effect of Nimodipine on platelet function in patients with subarachnoid haemorrhage. Stroke 1990; 21: 1283-1288.
21. Ohkuma H. et al. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1991; 22: 854-859.
22. Ghebremeskel K. et al. Blood fatty acid composition of pregnant and nonpregnant Korean women: red cells may act as a reservoir of arachidonic acid and docosohexanoic acid for utilization by the developing fetus. Lipids 2000; 35(5): 567-574.
23. Berry J., Logothetis J., Bovis M. Determination of the fatty acid composition of cerebrospinal fluid by gas-liquid chromatography. Neurobiology 1965; 15(12): 1089-1094.
24. Suzuki N. et al. Identification of 5-hydroxy eicosatetranoic acid in cerebrospinal fluid after subarachnoid hemorrhage. J Neurochem 1983; 41: 1186-1189.
25. Butler A. B., Bass N. H., Johnson R. N. Experimental subarachnoid hemorrhage in the rat: acute effects of blood components on mechanisms of cerebrospinal fluid absorption. Surgical Forum 1978; 29: 516-518.
26. Yamazaki H. et al. Vasospasm and injuries of cerebral arteries induced by activation of platelets in vivo: it may be due to thromboxane A2. Adv Prost Thrombox Leukot Res 1989; 19: 289-292.
27. Satoh S.-I. et al. The role of platelets in the development of cerebral vasospasm. Brain Res Bull 1991; 27: 663-668.
28. Vanhoutte P. M., Houston D. S. Platelets and vascular occlusion. Circulation 1985; 72(4): 728-734.
29. Castell L. M. Separation of peripheral blood lymphocytes with low platelet and erythrocyte contamination, using ADP aggregation. J Immunol Meth 1992; 146: 49-53.
30. Matsui T. et al. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Met 1991; 11: 143-149.
31. Erdodi F. et al. Phosphorylation of the 20,000-Da myosin light chain isoforms of arterial smooth muscle by myosin light chain kinase and protein kinase C. J Biochem Biophys 1988; 306(2): 583-591.
32. Osol G., Laher I., Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 1991; 68: 359-367.
33. Wang M., Reynaud D., Pace-Asciak C. R. In vivo stimulation of 12 (S)-lipooxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. Biochim Biophys Acta 1999; 1436: 354-362.
34. Prescott S. M. et al. Platelet-activating factor and related lipid mediators. Ann Rev Biochem 2000; 69: 419-445.
35. Hirashima Y. et al. Platelet activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1993; 78: 592-597.
36. Wang X. et al. Immediate early gene expression in vascular smooth muscle cells synergistically induced by hemolysate products. J Neurosurg 1999; 90: 1083-1090.
37. Hirashima Y. et al. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet activating factor antagonist, E5880. J Neurosurg 1996; 84: 826-830.
38. Hirashima Y. et al. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage -open clinical trial to investigate efficacy and safety. Neurol Med Chir 2001; 41(4): 165-175.
39. Suzuki H. et al. Effects of Tirilazad Mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage. Stroke 1999; 30: 450-456.
40. Hall E. D. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur J Anaesthesiol 1996; 13: 279-289.
41. Ichikawa K., Ito M., Hartshorne D. J. Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 1996; 271(9): 4733-4740.
42. Kranc K. R. et al. Oxidative degradation of bilirubin produces vasoactive compounds. Eur J Biochem 2000; 267: 7094-7101.
43. Clark J. F., Reilly M., Sharp F. R. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: A contributor to subarachnoid hemorrhage induced cerebral vasospasm. J Cereb Bl Fl Metab 2002; 22: 472-478.
44. Pyne G. J., Cadoux-Hudson T. A. D., Clark J. F. Magnesium protection against in vitro subarachnoid haemorrhage. Br J Neurosurg 2001; 15(5): 409-415.